NVO - Novo Nordisk not planning more supply chain acquisitions: report
2024-03-08 12:10:25 ET
More on Novo Nordisk
- Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified
- Novo Nordisk, A Very Healthy Pharma Stalwart
- Novo Nordisk: SOTP After Impressive FY23 And Weight Loss Going Mainstream, Maintain Buy
- Novo Nordisk sees launching new obesity drugs before Wegovy patent expires
- Novo Nordisk expects Wegovy approval in China this year: report